Bcl-2 encodes membrane-associated proteins that suppress programmed cell de
ath in cells of various origins. Compelling evidence suggests that bcl-2 is
also involved in neuronal differentiation and axonal regeneration. The hum
an Neuro-Teratocarcinoma (hNT) neurons constitute a terminally differentiat
ed human neuronal cell line that is derived from the Ntera-2/clone D1 (NT2)
precursors upon retinoic acid (RA) treatment. After transplantation into t
he central nervous system (CNS), the hNT neurons survive, engraft, maintain
their neuronal identity, and extend long neurite outgrowth. We were partic
ularly interested in the intracellular determinants that confer these post-
transplant characteristics to the hNT neurons. Thus, we asked whether the h
NT neurons express bcl-2 after transplantation into the rat striatum and if
RA induction of the neuronal lineage is mediated by bcl-2. The grafted hNT
neurons were first identified using three different antibodies that recogn
ize human-specific epitopes, anti-hMit, anti-hNuc, and NuMA. After a 1-mont
h post-transplant survival time, NuMA immunostaining revealed that 12% of t
he hNT neurons survived the transplantation. These neurons extended long ne
uritic processes within the striatum, as demonstrated using the human-speci
fic antibody against the midsize neurofilament subunit HO14. Importantly, w
e found that 85% of the implanted hNT neurons expressed bcl-2 and that the
in vitro induction of the neuronal lineage from the NT2 precursors with RA
resulted in an upregulation of bcl-2 expression. Together, these data sugge
st that the differentiation of the hNT neurons to a neuronal lineage could
be mediated at least partially by bcl-2. (C) 2001 Elsevier Science Inc.